文献速递眼底病与葡萄膜炎

与糖尿病视网膜病变相关的全身用药评估:基于英国生物样本库的巢式病例对照研究

Evaluation of systemic medications associated with diabetic retinopathy: a nested case-control study from the UK Biobank.
PubMed 文献 · Br J Ophthalmol · 2024-11-22

该研究基于英国生物样本库中有初级保健处方数据的人群,纳入3377例糖尿病视网膜病变(DR)病例并按年龄、性别、糖化血红蛋白、糖尿病病程、高血压和心血管病状态匹配3377例对照。多因素分析显示,短效胰岛素、中效胰岛素和磺脲类与DR发生风险升高相关,贝特类和Cox-2抑制剂与DR发生风险降低相关,五类药物均观察到剂量-反应关系。

要点

  • 短效胰岛素、中效胰岛素和磺脲类暴露与DR发生风险升高相关。
  • 贝特类和Cox-2抑制剂使用与DR发生风险降低相关。
  • 五类药物均观察到剂量-反应关系(均p<0.05)。

核心结论

  • 短效胰岛素、中效胰岛素和磺脲类使用与DR发生风险升高显著相关,贝特类和Cox-2抑制剂与DR发生风险降低相关。

研究设计与样本

  • 巢式病例对照研究,纳入英国生物样本库中有初级保健处方数据者,病例为医院统计编码或初级保健记录诊断或自报的DR,对照按年龄、性别、糖化血红蛋白、糖尿病病程、高血压状态和心血管病状态匹配。

主要发现

  • 共纳入3377例DR病例和3377例匹配对照。
  • 多因素logistic回归中,短效胰岛素暴露的DR发生风险OR为1.63(95%CI 1.22至2.18)。
  • 中效胰岛素暴露的DR发生风险OR为2.10(95%CI 1.60至2.75),磺脲类暴露的OR为1.30(95%CI 1.16至1.46)。
  • 贝特类使用与DR发生风险降低相关(OR 0.71;95%CI 0.53至0.94),Cox-2抑制剂使用与DR发生风险降低相关(OR 0.68;95%CI 0.58至0.79)。
  • 五类药物均观察到剂量-反应关系(均p<0.05)。

临床怎么用

  • 作者认为这些发现可能为糖尿病药物管理提供有价值的信息,并可作为糖尿病患者DR预防的参考。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: This study aims to investigate the associations between commonly used systemic medications and diabetic retinopathy (DR). METHODS: Individuals with linked primary care prescription data from the UK Biobank were included. Cases were defined as individuals with a Hospital Episode Statistics-coded or primary care recorded diagnosis of DR or self-reported DR. Controls were matched for age, sex, glycosylated haemoglobin, duration of diabetes mellitus (DM), hypertension status and cardiovascular disease status. ORs and 95% CIs were calculated using conditional univariate and multivariable logistic regression models. RESULTS: A total of 3377 case subjects with DR were included in the study and matched with 3377 control subjects. In multivariable logistic regression, increased odds of incident DR were observed for exposure to short-acting insulins (OR 1.63; 95% CI 1.22 to 2.18), medium-acting insulins (OR 2.10; 95% CI 1.60 to 2.75), sulfonylureas (OR 1.30; 95% CI 1.16 to 1.46). Instead, the use of fibrates (OR 0.71; 95% CI 0.53 to 0.94) and Cox-2 inhibitors (OR 0.68; 95% CI 0.58 to 0.79) was associated with decreased odds of incident DR. Dose-response relationships were observed for all five drug categories (all p<0.05). CONCLUSIONS: This study comprehensively investigated the associations between systemic medication use and DR and found significant associations between the use of short-acting insulins, medium-acting insulins and sulfonylureas with increased odds of incident DR. In contrast, fibrates and Cox-2 inhibitors were associated with decreased odds of incident DR. These findings may provide valuable insights into DM medication management and serve as a reference for the prevention of DR in patients with DM.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Jin G, Ma Y, Zheng D, et al. Evaluation of systemic medications associated with diabetic retinopathy: a nested case-control study from the UK Biobank. Br J Ophthalmol. 2024. PMID: 38769011. doi:10.1136/bjo-2023-324930

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。